BGI Genomics Monthly Spotlight - December 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Strengthening Global Health Collaboration: Saudi Health Minister Visits BGI Genomics
We were honored to welcome H.E. Fahad AlJalajel, Saudi Minister of Health, and his delegation to the BGI center as the first stop during his visit to China. Our executive team engaged in meaningful discussions about advancing genomics and precision medicine, reflecting shared commitments to innovation and public health.
Key MOUs signed with National Unified Procurement Company "NUPCO" and Al-Dawaa Medical Services Co., witnessed by Minister Al-Jalajel, paving the way for deeper partnerships.
Pakistani Delegation Strengthens Partnership with BGI Genomics in Precision Medicine
On December 13th, Maryam Nawaz Sharif, Chief Minister of Punjab, Pakistan, led a delegation to BGI Genomics to sign a groundbreaking Memorandum of Understanding (MoU).
This partnership focuses on building medical testing platforms, enhancing disease prevention, and advancing Precision Medicine services with the Government of Punjab in Pakistan.
Zhao Lijian: Healthcare Innovations in 2025 | BioSpectrum Asia
Great to have Zhao Lijian, CEO of BGI Genomics, featured in BioSpectrum Asia "2025 Trends" cover story! In the article, he sheds knowledge and highlights transformative healthcare innovations, focusing on AI applications in Clinical Practice, Personalized Treatment, and Proactive Health Monitoring.
领英推荐
BGI Genomics: Advancing Precision Medicine Globally
Technology transfer is more than just the exchange of innovations—it’s about delivering advanced health solutions that empower communities and transform healthcare systems. We are truly honored to have our efforts recognized by our valued partners: Zentya in Slovakia and NIMGenetics in Spain share their experiences on how BGI Genomics’ initiatives are advancing genetic testing and improving patient outcomes across the globe.
Fostering a Healthy Pregnancy through Early Testing: Sonia’s Story
"Knowing we were doing everything to ensure a healthy pregnancy gave us peace of mind," says Sonia Bumbel from Timisoara, Romania.
With BGI Genomics' NIFTY? Test and VISTA? Carrier Screening, Sonia and her husband Claudiu embraced prenatal screening and genetic testing, ensuring confidence and care for their growing family.
Unlocking Clues in Blood: Li Jia's Multi-Omics Revolution in Disease Prevention | Chat!DNA
Did you know that your blood doesn’t just reflect your current health—it holds the key to understanding future risks?
In the latest of our Chat!DNA Expert Interview, we spotlight Li Jia, a dedicated research scientist at BGI Genomics’ Institute of Intelligent Medical Research (IIMR), who has been decoding the hidden bio-information in blood. His work is transforming how we detect and predict gestational diseases, tumor risks, and chronic conditions.
Digital cancer pathologist; cybersecurity architect.
1 个月Successful AI medical projects. Lack of interpretabily and unexplainable decisions are risky in DL softwares. methods must make sense and clinically relevant Most algorithms in medical DL are not subjected to rigorous, randomized control trials and vendors make mis-sales. Use them only as a decision-making aid. Concentrate on it's performance and validation. Successful AI adoption: *Start small with a big goal in mind. *Focus on business need, not on technology. *A.I success is about culture and people.